NightBalance closes EUR 12.5 million Series B financing.

NightBalance closes EUR 12.5 million Series B financing.

Delft, the Netherlands, July 5, 2016  – NightBalance BV, a leading innovator of obstructive sleep apnea (OSA) technology, today announced the completion of a EUR 12.5 million Series B financing round led by INKEF Capital and Gilde Healthcare Partners. Existing investors Thuja Capital, Health Innovation Fund, and Van Herk Ventures also participated. Dirk Kersten from INKEF, and Pieter van der Meer from Gilde will join the supervisory board, which will be chaired by Jan Keltjens and further strengthened with the appointment of Geoff Waters.

Read the official Press Release.